Inventor · disambiguated record
Xinglu Zhou
Also filed as: ZHOU XINGLU
1 granted patent·5 pending applications·0 citations·filing 2017–2022
7Inventor score
Files withHANGZHOU HEALZEN THERAPEUTICS CO LTD4HANGZHOU HERTZ PHARMACEUTICAL CO LTD1NEUSHEN THERAPEUTICS SHANGHAI CO LTD1
Top patents by PatentIndex Score
6 records- 0153US2025034135A1Anti-apoptotic protein bcl-2 inhibitor, pharmaceutical composition and uses thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0250US2024360146A1Bruton's tyrosine kinase and mutant degrader, composition and application thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0346US2024317689A1Potassium channel modulator, composition and applicationNEUSHEN THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0446US2024043430A1CRYSTAL FORM OF CASEIN KINASE 1e INHIBITOR AND PREPARATION METHOD AND USE THEREOFHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0539US2022251092A1Casein kinase 1epsilon inhibitor, pharmaceutical composition and application thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 0628US10711006B2Selective Bruton's tyrosine kinase inhibitor and use thereofHANGZHOU HERTZ PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 14, 2020·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Xinglu Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →